Company News | NeuroTherapia, Inc.

Jul 6, 20201 min read

NeuroTherapia completes enrollment in Phase 1 first-in-human trial of NTRX-07

NeuroTherapia has completed enrollment of its Phase 1 single dose study of NTRX-07 in normal volunteers. Top line data is expected to be...

Oct 31, 20192 min read

NeuroTherapia Initiates First-In-Human Clinical Trials of NTRX-07 For Alzheimer’s Disease

NeuroTherapia, Inc., a Cleveland Clinic spin-off company, has started its first-in-human Phase I clinical trial of NTRX-07, a new drug...

Oct 13, 20192 min read

NeuroTherapia to Start Clinical Trials of NTRX-07 For Alzheimer’s Disease

CLEVELAND, OH – NeuroTherapia, Inc., a Cleveland Clinic spin-off company, will be starting clinical trials of NTRX-07, a new drug...

Jun 13, 20191 min read

Alzheimer's Association Supports First Human Trials of NTRX-07

NeuroTherapia has received funding from the Alzheimer's Association to support the first human trials of NTRX-07, a novel new therapy...

103 views